Cargando…
Inhibition of RUNX2 Transcriptional Activity Blocks the Proliferation, Migration and Invasion of Epithelial Ovarian Carcinoma Cells
Previously, we have identified the RUNX2 gene as hypomethylated and overexpressed in post-chemotherapy (CT) primary cultures derived from serous epithelial ovarian cancer (EOC) patients, when compared to primary cultures derived from matched primary (prior to CT) tumors. However, we found no differe...
Autores principales: | Wang, Zhi-Qiang, Keita, Mamadou, Bachvarova, Magdalena, Gobeil, Stephane, Morin, Chantale, Plante, Marie, Gregoire, Jean, Renaud, Marie-Claude, Sebastianelli, Alexandra, Trinh, Xuan Bich, Bachvarov, Dimcho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790792/ https://www.ncbi.nlm.nih.gov/pubmed/24124450 http://dx.doi.org/10.1371/journal.pone.0074384 |
Ejemplares similares
-
The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells
por: Faddaoui, Adnen, et al.
Publicado: (2016) -
Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation
por: Wang, Zhi-Qiang, et al.
Publicado: (2014) -
Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner
por: Sheta, Razan, et al.
Publicado: (2017) -
BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism
por: Wang, Zhi-Qiang, et al.
Publicado: (2015) -
Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy
por: Sheta, Razan, et al.
Publicado: (2020)